GH1 and Insulin resistance: These include elevated sympathetic nervous system activity, alterations of cortisol and growth hormone rhythms, alteration of appetite-regulating hormones, elevated inflammatory markers, and adipocyte insulin resistance, leading to increased insulin resistance without adequate insulin secretory response [6–9].